Australia · Delayed Price · Currency is AUD Island Pharmaceuticals Statistics
Total Valuation
ASX:ILA has a market cap or net worth of AUD 125.76 million. The enterprise value is 112.89 million.
| Market Cap | 125.76M |
| Enterprise Value | 112.89M |
Important Dates
The last earnings date was Friday, August 28, 2026.
| Earnings Date | Aug 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ASX:ILA has 295.92 million shares outstanding. The number of shares has increased by 55.94% in one year.
| Current Share Class | 295.92M |
| Shares Outstanding | 295.92M |
| Shares Change (YoY) | +55.94% |
| Shares Change (QoQ) | +13.50% |
| Owned by Insiders (%) | 40.21% |
| Owned by Institutions (%) | 4.60% |
| Float | 150.84M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 444.94 |
| PB Ratio | 9.34 |
| P/TBV Ratio | 9.89 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 24.62
| Current Ratio | 24.62 |
| Quick Ratio | 24.43 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -95.50% and return on invested capital (ROIC) is -62.67%.
| Return on Equity (ROE) | -95.50% |
| Return on Assets (ROA) | -60.12% |
| Return on Invested Capital (ROIC) | -62.67% |
| Return on Capital Employed (ROCE) | -76.79% |
| Weighted Average Cost of Capital (WACC) | 4.92% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +93.18% in the last 52 weeks. The beta is 0.12, so ASX:ILA's price volatility has been lower than the market average.
| Beta (5Y) | 0.12 |
| 52-Week Price Change | +93.18% |
| 50-Day Moving Average | 0.43 |
| 200-Day Moving Average | 0.42 |
| Relative Strength Index (RSI) | 44.45 |
| Average Volume (20 Days) | 157,060 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ASX:ILA had revenue of AUD 282,657 and -9.84 million in losses. Loss per share was -0.04.
| Revenue | 282,657 |
| Gross Profit | -2.58M |
| Operating Income | -10.33M |
| Pretax Income | -9.84M |
| Net Income | -9.84M |
| EBITDA | -10.23M |
| EBIT | -10.33M |
| Loss Per Share | -0.04 |
Balance Sheet
The company has 12.87 million in cash and no debt, with a net cash position of 12.87 million or 0.04 per share.
| Cash & Cash Equivalents | 12.87M |
| Total Debt | n/a |
| Net Cash | 12.87M |
| Net Cash Per Share | 0.04 |
| Equity (Book Value) | 13.46M |
| Book Value Per Share | 0.05 |
| Working Capital | 12.72M |
Cash Flow
| Operating Cash Flow | -4.83M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 105,289 |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | -3,656.31% |
| Pretax Margin | -3,482.66% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ASX:ILA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -55.94% |
| Shareholder Yield | -55.94% |
| Earnings Yield | -7.83% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ASX:ILA has an Altman Z-Score of 106.2 and a Piotroski F-Score of 4.
| Altman Z-Score | 106.2 |
| Piotroski F-Score | 4 |